SatixFy Announces Nine Months 2023 Results
REHOVOT, Israel–(BUSINESS WIRE)–SatixFy Communications Ltd. (the “Company” or “SatixFy”) (NYSE AMERICAN: SATX), a pioneering force in next-generation... Read more.
KromaTiD and SeQure Dx enter partnership agreement to offer comprehensive, IND-enabling gene editing services supporting cell and gene therapy research
LONGMONT, Colo. & WALTHAM, Mass.–(BUSINESS WIRE)–KromaTiD and SeQure Dx announced today a partnership to market a comprehensive and integrated analysis... Read more.
Musixmatch Appoints Rio Caraeff as Chief Business Officer
Industry Veteran Brings Nearly Three Decades of Leadership and Experience Across the Music and Technology Landscape BOLOGNA, Italy–(BUSINESS WIRE)–Musixmatch,... Read more.
Lynn Smith joins National Bank of Coxsackie as VP/Chief Credit Officer
LATHAM, N.Y.–(BUSINESS WIRE)–The National Bank of Coxsackie announced today that Lynn Smith joined National Bank of Coxsackie as its their Vice President/Chief... Read more.
Data Theorem Showcasing Latest API Security Innovations Protecting Applications from Threats and Attacks at Apidays Paris Next Week
Company Hosting Workshop Titled “What is Missing in Your API Security Program?” on Dec. 6; Presenting “Cloud APIs, ChatGPT 4-Turbo, and Attack Path Visualization”... Read more.
ATCC Announces Award from NIAID to Consolidate its BEI Resources and NIH HIV Reagent Programs
The Biological and Emerging Infections Research Resources Program (BEI-RRP) contract, which merges the two programs, represents the fourth recompete award with NIAID... Read more.
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2023
– Recognition Marks Alnylam’s Ninth Year in a Row on this Prestigious List, and the Third Consecutive Year Ranking #1 – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam... Read more.
RBLX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Roblox Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Roblox Corporation (NYSE: RBLX)... Read more.
Neurogene Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome
Two pediatric patients with Rett syndrome dosed in the United States with NGN-401, Neurogene’s lead gene therapy product candidate leveraging its proprietary EXACT... Read more.
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
– Rapid, robust, and clinically significant reduction of depression symptoms observed after a single dose of CYB003, with a clear incremental benefit of a... Read more.